These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 33275637)

  • 1. The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    Bae CR; Zhang H; Kwon YG
    PLoS One; 2020; 15(12):e0243497. PubMed ID: 33275637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.
    Yang YM; Wang Z; Matsuda M; Seki E
    Arch Pharm Res; 2021 Feb; 44(2):230-240. PubMed ID: 33486695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice.
    Wang C; Duan X; Sun X; Liu Z; Sun P; Yang X; Sun H; Liu K; Meng Q
    Food Funct; 2016 Sep; 7(9):3716-23. PubMed ID: 27487733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.
    Suzuki-Kemuriyama N; Abe A; Uno K; Ogawa S; Watanabe A; Sano R; Yuki M; Miyajima K; Nakae D
    Lipids Health Dis; 2020 Dec; 19(1):251. PubMed ID: 33317575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.
    Okishio S; Yamaguchi K; Ishiba H; Tochiki N; Yano K; Takahashi A; Kataoka S; Okuda K; Seko Y; Liu Y; Fujii H; Takahashi D; Ito Y; Kamon J; Umemura A; Moriguchi M; Yasui K; Okanoue T; Itoh Y
    Sci Rep; 2020 Nov; 10(1):19578. PubMed ID: 33177546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y
    Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
    Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet.
    Ibusuki R; Uto H; Arima S; Mawatari S; Setoguchi Y; Iwashita Y; Hashimoto S; Maeda T; Tanoue S; Kanmura S; Oketani M; Ido A; Tsubouchi H
    Liver Int; 2013 Nov; 33(10):1549-56. PubMed ID: 23682724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4,4-Diallyl curcumin bis(2,2-hydroxymethyl)propanoate ameliorates nonalcoholic steatohepatitis in methionine-choline-deficient diet and Western diet mouse models.
    Yang LC; Wang CC; Lee DY; Lin WC; Kuo SC; Juang SH; Hsieh MT
    Chem Biol Drug Des; 2024 May; 103(5):e14532. PubMed ID: 38725089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
    Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
    Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice.
    Yang A; Yan X; Fan X; Shi Y; Huang T; Li W; Chen W; Jia J; You H
    Hepatol Int; 2021 Oct; 15(5):1122-1135. PubMed ID: 34014450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
    Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-Restricted Feeding Ameliorates Methionine-Choline Deficient Diet-Induced Steatohepatitis in Mice.
    Jung IR; Ahima RS; Kim SF
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
    Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy.
    Ji G; Wang Y; Deng Y; Li X; Jiang Z
    Lipids Health Dis; 2015 Oct; 14():134. PubMed ID: 26498332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis.
    Kurikawa N; Takagi T; Wakimoto S; Uto Y; Terashima H; Kono K; Ogata T; Ohsumi J
    Biol Pharm Bull; 2013; 36(2):259-67. PubMed ID: 23370355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis.
    Hammoutene A; Biquard L; Lasselin J; Kheloufi M; Tanguy M; Vion AC; Mérian J; Colnot N; Loyer X; Tedgui A; Codogno P; Lotersztajn S; Paradis V; Boulanger CM; Rautou PE
    J Hepatol; 2020 Mar; 72(3):528-538. PubMed ID: 31726115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats.
    Hayashizaki-Someya Y; Kurosaki E; Takasu T; Mitori H; Yamazaki S; Koide K; Takakura S
    Eur J Pharmacol; 2015 May; 754():19-24. PubMed ID: 25701721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.